Early detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment

References

• US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Princ Pract Clin Trial Med. 2017.
   Google Scholar
• Freifeld AG, Infectious Diseases Society of America, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56–93.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections. Version 2. 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf.
   Google Scholar
• Cannas G, Pautas C, Raffoux E, et al. Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial. Leuk Lymphoma. 2012;53(6):1068–1076.
   PubMed Web of Science ®Google Scholar
• Kato H, Japan Adult Leukemia Study Group, Fujita H, Akiyama N, et al. Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols. Support Care Cancer. 2018;26(12):4187–4198.
   PubMed Web of Science ®Google Scholar
• Sickles EA, Young VM, Greene WH, et al. Pneumonia in acute leukemia. Ann Intern Med. 1973;79(4):528–534.
   PubMed Web of Science ®Google Scholar
• Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975;135(5):715–719.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium – A groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013;31(22):2810–2818.
   PubMed Web of Science ®Google Scholar
• Hersh EM, Bodey GP, Nies BA, et al. Causes of death in acute leukemia: a ten-year study of 414 patients from 1954–1963. JAMA. 1965;193:105–109.
   PubMed Web of Science ®Google Scholar
• Zuckermann J, Moreira LB, Stoll P, et al. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol. 2008;87(2):139–145.
   PubMed Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004;279(47):48487–48490.
   PubMed Web of Science ®Google Scholar
• Emery P, Gabay C, Kraan M, et al. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int. 2007;27(9):793–806.
   PubMed Web of Science ®Google Scholar
• Fluri F, Morgenthaler NG, Mueller B, et al. Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS One. 2012;7(10):e48309.
   PubMed Web of Science ®Google Scholar
• Unkila-Kallio L, Kallio MJ, Eskola J, et al. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics. 1994;93(1):59–62.
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217.
   PubMed Web of Science ®Google Scholar
• de Oliveira VM, Moraes RB, Stein AT, et al. Accuracy of C - Reactive protein as a bacterial infection marker in critically immunosuppressed patients: A systematic review and meta-analysis. J Crit Care. 2017;42:129–137.
   PubMed Web of Science ®Google Scholar
• Wu C-W, Wu J-Y, Chen C-K, et al. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer. 2015;23(10):2863–2872.
   PubMed Web of Science ®Google Scholar
• Ram R, Yeshurun M, Farbman L, et al. Elevation of CRP precedes clinical suspicion of bloodstream infections in patients undergoing hematopoietic cell transplantation. J Infect. 2013;67(3):194–198.
   PubMed Web of Science ®Google Scholar
• Henderson H, Luterbach CL, Cober E, et al. The Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections. Clin Infect Dis. 2019;70(9):1826–1833.
   Web of Science ®Google Scholar
• Battle SE, Augustine MR, Watson CM, et al. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019;47(4):571–578.
   PubMed Web of Science ®Google Scholar
• Thursky KA, Worth LJ. Can mortality of cancer patients with fever and neutropenia be improved? Curr Opin Infect Dis. 2015;28(6):505–513.
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755.
   PubMed Web of Science ®Google Scholar
• Chan SM, Chadwick J, Young DL, et al. Intensive serial biomarker profiling for the prediction of neutropenic fever in patients with hematologic malignancies undergoing chemotherapy: A pilot study. Hematol Rep. 2014;6(2):5466– 5431.
   PubMedGoogle Scholar
• Rose PE, Johnsdon SA, Meakin M, et al. Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol. 1981;34(3):263–266.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Kuittinen T, Matinlauri I, et al. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma. 2008;49(3):495–501.
   PubMed Web of Science ®Google Scholar